30 years of historical data (1996–2025) · Consumer Defensive · Household & Personal Products
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
The Clorox Company trades at 19.5x earnings, 65% below its 5-year average of 56.3x, sitting at the 33rd percentile of its historical range. Compared to the Consumer Defensive sector median P/E of 21.6x, the stock trades at a discount of 10%. On a free-cash-flow basis, the stock trades at 21.8x P/FCF, 18% below the 5-year average of 26.6x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $16.6B | $14.9B | $17.0B | $19.7B | $17.5B | $22.9B | $28.0B | $19.9B | $17.8B | $17.5B | $18.2B |
| Enterprise Value | $19.3B | $17.6B | $19.7B | $22.3B | $20.4B | $25.7B | $30.3B | $22.4B | $20.1B | $19.3B | $20.1B |
| P/E Ratio → | 19.50 | 18.42 | 60.65 | 132.53 | 37.80 | 32.24 | 29.85 | 24.23 | 21.64 | 25.00 | 28.13 |
| P/S Ratio | 2.34 | 2.10 | 2.40 | 2.67 | 2.46 | 3.12 | 4.17 | 3.20 | 2.91 | 2.93 | 3.16 |
| P/B Ratio | 32.79 | 30.96 | 34.62 | 50.90 | 23.96 | 38.69 | 30.84 | 35.55 | 24.51 | 32.34 | 61.37 |
| P/FCF | 21.85 | 19.61 | 35.26 | 21.24 | 32.65 | 24.24 | 21.68 | 25.28 | 22.82 | 27.52 | 30.08 |
| P/OCF | 16.95 | 15.21 | 24.51 | 17.06 | 22.22 | 17.95 | 18.12 | 20.03 | 18.27 | 20.20 | 23.43 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
The Clorox Company's enterprise value stands at 13.8x EBITDA, 24% below its 5-year average of 18.1x. The Consumer Defensive sector median is 12.3x, placing the stock at a 12% premium on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.48 | 2.78 | 3.02 | 2.87 | 3.51 | 4.50 | 3.61 | 3.29 | 3.23 | 3.50 |
| EV / EBITDA | 13.83 | 12.62 | 17.14 | 20.98 | 22.16 | 17.78 | 20.95 | 17.41 | 15.59 | 15.02 | 16.33 |
| EV / EBIT | 16.40 | 14.96 | 39.39 | 65.42 | 28.96 | 25.93 | 23.68 | 20.13 | 17.91 | 17.32 | 18.91 |
| EV / FCF | — | 23.17 | 40.86 | 23.99 | 38.11 | 27.25 | 23.42 | 28.56 | 25.83 | 30.31 | 33.23 |
Margins and return-on-capital ratios measuring operating efficiency
The Clorox Company earns an operating margin of 16.6%, significantly above the Consumer Defensive sector average of 1.1%. Operating margins have expanded from 11.2% to 16.6% over the past 3 years, signaling improving operational efficiency. Return on equity of 166.3% is exceptionally high, though this is partly amplified by negative book value driven by aggressive share buybacks — well above the sector median of 7.8%. ROIC of 27.7% represents excellent returns on invested capital versus a sector median of 5.7%.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 45.0% | 45.0% | 42.6% | 38.9% | 35.0% | 43.3% | 45.4% | 43.6% | 43.5% | 44.6% | 45.2% |
| Operating Margin | 16.6% | 16.6% | 12.9% | 11.2% | 9.8% | 16.9% | 18.8% | 17.8% | 18.4% | 18.8% | 18.5% |
| Net Profit Margin | 11.4% | 11.4% | 3.9% | 2.0% | 6.5% | 9.7% | 14.0% | 13.2% | 13.4% | 11.7% | 11.2% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 166.3% | 166.3% | 63.6% | 26.7% | 69.9% | 94.7% | 128.0% | 127.6% | 129.8% | 167.1% | 312.3% |
| ROA | 14.3% | 14.3% | 4.8% | 2.5% | 7.4% | 11.3% | 16.6% | 16.1% | 17.1% | 15.4% | 14.9% |
| ROIC | 27.7% | 27.7% | 22.4% | 18.8% | 14.7% | 28.1% | 30.2% | 26.7% | 31.3% | 37.2% | 38.7% |
| ROCE | 30.2% | 30.2% | 22.3% | 19.7% | 16.1% | 27.3% | 29.9% | 29.4% | 34.0% | 39.2% | 37.3% |
Solvency and debt-coverage ratios — lower is generally safer
The Clorox Company carries a Debt/EBITDA ratio of 2.1x, which is manageable (36% below the sector average of 3.2x). Net debt stands at $2.7B ($2.9B total debt minus $167M cash). Interest coverage of 11.7x signals virtually no risk of debt distress — earnings comfortably cover interest obligations.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 5.98 | 5.98 | 5.90 | 7.54 | 4.26 | 5.35 | 3.44 | 4.80 | 3.42 | 4.05 | 7.78 |
| Debt / EBITDA | 2.06 | 2.06 | 2.52 | 2.75 | 3.37 | 2.19 | 2.16 | 2.08 | 1.92 | 1.71 | 1.88 |
| Net Debt / Equity | — | 5.63 | 5.49 | 6.59 | 4.01 | 4.81 | 2.48 | 4.60 | 3.24 | 3.28 | 6.43 |
| Net Debt / EBITDA | 1.94 | 1.94 | 2.35 | 2.41 | 3.17 | 1.97 | 1.56 | 2.00 | 1.82 | 1.38 | 1.55 |
| Debt / FCF | — | 3.57 | 5.59 | 2.75 | 5.46 | 3.01 | 1.74 | 3.27 | 3.02 | 2.79 | 3.15 |
| Interest Coverage | 11.67 | 11.67 | 8.89 | 8.03 | 7.18 | 13.31 | 13.60 | 12.16 | 14.24 | 13.68 | 13.02 |
Short-term solvency ratios and asset-utilisation metrics
The current ratio of 0.84x is below 1.0, meaning current liabilities exceed current assets. The current ratio has declined from 0.95x to 0.84x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.84 | 0.84 | 1.03 | 0.95 | 0.97 | 0.89 | 1.42 | 0.91 | 1.09 | 0.84 | 0.95 |
| Quick Ratio | 0.57 | 0.57 | 0.63 | 0.59 | 0.54 | 0.52 | 1.10 | 0.55 | 0.67 | 0.58 | 0.67 |
| Cash Ratio | 0.09 | 0.09 | 0.13 | 0.19 | 0.10 | 0.16 | 0.61 | 0.08 | 0.11 | 0.23 | 0.26 |
| Asset Turnover | — | 1.28 | 1.23 | 1.24 | 1.15 | 1.16 | 1.08 | 1.21 | 1.21 | 1.31 | 1.28 |
| Inventory Turnover | 7.48 | 7.48 | 6.39 | 6.49 | 6.11 | 5.53 | 8.08 | 6.84 | 6.84 | 7.20 | 7.13 |
| Days Sales Outstanding | — | 42.18 | 35.76 | 33.99 | 34.97 | 30.03 | 35.19 | 37.06 | 35.76 | 34.53 | 36.05 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
The Clorox Company returns 5.8% to shareholders annually — split between a 3.8% dividend yield and 2.0% buyback yield. The payout ratio of 74.3% is elevated — while still covered by earnings, there is limited headroom for dividend increases. The earnings yield of 5.1% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 3.8% | 4.0% | 3.5% | 3.0% | 3.3% | 2.4% | 1.9% | 2.5% | 2.5% | 2.4% | 2.2% |
| Payout Ratio | 74.3% | 74.3% | 212.5% | 391.3% | 123.6% | 78.6% | 56.8% | 59.8% | 54.7% | 58.8% | 61.4% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 5.1% | 5.4% | 1.6% | 0.8% | 2.6% | 3.1% | 3.4% | 4.1% | 4.6% | 4.0% | 3.6% |
| FCF Yield | 4.6% | 5.1% | 2.8% | 4.7% | 3.1% | 4.1% | 4.6% | 4.0% | 4.4% | 3.6% | 3.3% |
| Buyback Yield | 2.0% | 2.2% | 0.0% | 0.0% | 0.1% | 4.0% | 0.9% | 3.3% | 1.5% | 1.0% | 1.4% |
| Total Shareholder Yield | 5.8% | 6.3% | 3.5% | 3.0% | 3.4% | 6.4% | 2.8% | 5.8% | 4.1% | 3.4% | 3.6% |
| Shares Outstanding | — | $124M | $125M | $124M | $124M | $127M | $128M | $130M | $132M | $132M | $132M |
Compare CLX with 5 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| CLXYou | $17B | 19.5 | 13.8 | 21.8 | 45.0% | 16.6% | 166.3% | 27.7% | 2.1 |
| PG | $389B | 25.7 | 17.8 | 27.7 | 51.2% | 24.3% | 31.1% | 20.1% | 1.5 |
| UL | $161B | 27.3 | 14.4 | 17.6 | 100.0% | 15.5% | 26.5% | 15.3% | 2.7 |
| KMB | $37B | 18.4 | 14.0 | 22.6 | 35.6% | 14.5% | 147.9% | 23.2% | 2.3 |
| CHD | $25B | 34.7 | 20.1 | 22.7 | 44.7% | 17.4% | 17.6% | 13.9% | 1.7 |
| TANH | $932178 | -0.1 | -5.3 | 0.2 | 20.8% | 9.3% | -2.6% | 3.0% | 0.8 |
| Consumer Defensive Median | — | 21.6 | 12.3 | 16.4 | 40.7% | 1.1% | 7.8% | 5.7% | 3.2 |
Peers based on L4 peer group classification. Compare multiple stocks →
Includes 30+ ratios · 30 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how CLX stacks up against sector leader The Procter & Gamble Company.
Start ComparisonThe Clorox Company's current P/E ratio is 19.5x. The historical average is 32.9x. This places it at the 33th percentile of its historical range.
The Clorox Company's current EV/EBITDA is 13.8x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 13.6x.
The Clorox Company's return on equity (ROE) is 166.3%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 115.9%.
Based on historical data, The Clorox Company is trading at a P/E of 19.5x. This is at the 33th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
The Clorox Company's current dividend yield is 3.81% with a payout ratio of 74.3%.
The Clorox Company has 45.0% gross margin and 16.6% operating margin. Operating margin between 10-20% is typical for established companies.
The Clorox Company's Debt/EBITDA ratio is 2.1x, indicating moderate leverage. A ratio between 2-4x is manageable but warrants monitoring.